ATOSSA THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
ATOSSA THERAPEUTICS, INC. (ATOS) had Additional Paid in Capital, Common Stock of $254.89 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2023-11-13
- 2023-09-30: Additional Paid in Capital, Common Stock $254.89M.
- 2023-06-30: Additional Paid in Capital, Common Stock $253.96M.
- 2023-03-31: Additional Paid in Capital, Common Stock $252.36M.
- 2022-12-31: Additional Paid in Capital, Common Stock $250.78M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2023-09-30 | $254.89M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $253.96M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $252.36M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $250.78M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $249.24M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $247.57M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $245.80M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $244.00M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $242.37M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $240.02M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $229.50M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $129.89M 10-K · filed 2022-02-28 | $129.89M 10-K · filed 2021-03-31 |
| 2020-09-30 | $111.78M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $107.00M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $105.60M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $104.91M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $104.16M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $103.40M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $98.06M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $82.20M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $80.81M 10-Q · filed 2018-11-14 | |
| 2017-12-31 | $71.89M 10-K · filed 2019-03-28 | |
| 2017-03-31 | $60.48M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $60.34M 10-Q · filed 2017-05-11 | |
| 2016-09-30 | $60.14M 10-Q/A · filed 2017-03-21 | |
| 2016-06-30 | $57.36M 10-Q/A · filed 2017-03-21 | |
| 2016-03-31 | $57.00M 10-Q/A · filed 2017-03-21 | |
| 2015-12-31 | $54.64M 10-K/A · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |